Recent insider trading activity from Bhalla Narinder Pal, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 13, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Bhalla Narinder Pal | Chief Medical Officer | A | Common Stock | 49500 | $0.00 | 49,500.0000 | 72,987,327 | 9999.99% | 0.07% |
| Feb. 13, 2026 | Lexeo Therapeutics, Inc. | $LXEO | Bhalla Narinder Pal | Chief Medical Officer | A | Stock Option (right to buy) | 297000 | $0.00 | 297,000.0000 | 72,987,327 | 9999.99% | 0.41% |